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The diversity of non-coding RNAs
Since Phillip Sharp first discovered introns in 1977, increasing evidence has demonstrated the complexity of our genome and has shaken well-established dogmas several times. John Mattick (Garvan Institute of Medical Research, Australia) unraveled a new form of fourdimensional organization of the genome in which alternatively spliced, but not constitutive, exons are preorganized around active promoters and enhancers. Antonio Giraldez (Yale University, USA) combined genome-wide ribosome profiling with mass spectrometry in zebrafish to identify more than 800 micropeptides that are Correspondence: reini.luco@igh.cnrs.fr Institut de Genetique Humaine -CNRS UPR1142, Montpellier, France translated from ncRNAs, conserved in vertebrates and expressed mostly in early development, and that are important for gastrulation and heart development. In addition, Igor Ulitsky (Weizmann Institute, Israel) found common features between the open reading frames (ORFs) in the 5'UTR of ribosome-associated long intergenic non-coding RNAs (lincRNAs) and inefficiently translated mRNAs, which could explain the untranslatable nature of lincRNAs.
Small non-coding RNAs
MicroRNAs (miRNAs) are small (approximately 21 nucleotides in length) regulatory RNAs that control gene expression by either inhibiting protein translation or inducing mRNA decay by imperfectly base-pairing to 3'UTRs of target mRNAs. The biogenesis of miRNAs is under tight temporal and spatial regulation, and misregulation of these processes is often associated with disease. Narry Kim (Institute for Basic Science and Seoul National University, Korea) showed that during early development in flies, most mature miRNAs lose a 3' adenyl tail important for miRNA stability, and suggested that this could be implicated in the maternal-to-zygote transition. Eran Hornstein (Weizmann Institute of Science, Israel) ameliorated the neuromuscular deterioration of a classic mouse model of amyotrofic lateral sclerosis by recovering pre-miRNA processing via a small molecule that potentiates Dicer activity. In addition, Elisa Izaurralde (Max Planck Institute for Development Biology, Germany) showed that the enrichment of tryptophan residues along the interacting pockets of GW182 with miRNA-loaded Argonaute and RNA decapping and deadenylase complexes is essential for the miRNAmediated translational repression of mRNAs. Finally, David Bartel (HHMI/MIT/Whitehead Institute, USA) showed that in early zebrafish development, miRNAs inhibit protein translation by shortening the mRNA polyA tail rather than inducing degradation of the transcript, a mechanism that is predominant later in development.
Regarding other small RNAs (sRNAs), it is well established in plants and invertebrates that RNA interference (RNAi)-dependent silencing pathways regulate various processes, including regulation of gene expression, protection of genome integrity and innate immune responses against viruses. Olivier Voinnet (ETH Zurich, Switzerland) showed that in mammalian stem cells, antiviral small interfering RNAs (siRNAs) are also generated for defense against pathogens. In the animal germline, however, PIWI-interacting RNAs (piRNAs) are in charge of silencing mutagenic transposable elements. Eva-Maria Weick (The Wellcome Trust/Cancer Research UK Gurdon Institute, UK) demonstrated that there are different mechanisms of piRNA biogenesis in Caenorhabditis elegans depending on environmental conditions, with the synthesis of a novel population of type 2 piRNAs under stress. Maike Laussmann (EMBL Heidelberg, Germany) showed by live cell imaging that key proteins in the piRNA pathway are highly dynamic and present different retention times in the cytoplasm granules (also known as nuages) in vivo, suggesting different functions in piRNA biogenesis.
Long non-coding RNAs
Since the discovery of Xist and HOTAIR, thousands of long non-coding RNAs (lncRNAs) have been identified and classified depending on their genomic location, whether they are intra-or intergenic, and according to their strand-specificity. lncRNAs have been increasingly shown to be involved in a wide range of regulatory functions, from the regulation of transcription to splicing, and in tethering chromatin-modifying complexes to DNA. One of the best-studied examples is Xist, which is essential for X chromosome inactivation. Jeannie Lee (Massachusetts General Hospital, USA) showed that Xist-mediated recruitment of polycomb repressive complex 2 (PRC2) during X inactivation is non-random with highly localized spreading along gene-rich domains first, whereas during maintenance all regions are covered at once, suggesting the existence of an epigenetic memory. Edith Heard (Institut Curie, France) presented the kinetics of X inactivation showing that Xist coating and loss of euchromatin marks precede jumonji, AT rich interactive domain 2 (JARID2)-dependent recruitment of PRC2 for gene silencing. Roberto Bonasio (HHMI/NYU School of Medicine, USA) confirmed a lncRNAdependent interaction and combined recruitment of JARID2 and enhancer of zeste homolog 2 (Drosophila) (EZH2) to target genes in human induced pluripotent stem cells. Maite Huarte (CIMA/University of Navarra, Spain) described a novel and conserved nuclear lincRNA, PINT (p53-induced noncoding transcript), that is downregulated in tumor cells and induced by the tumor suppressor p53. Huarte demonstrated that PINT is important for cell proliferation and survival via direct recruitment of PRC2 to pro-apoptotic genes. Howard Chang (Stanford University, USA) introduced an innovative genome-wide technique for analyzing chromatin accessibility by in vitro random insertion of a known transposon sequence into preferentially open chromatin, allowing posterior detection of the integration sites by deep sequencing (assay of transposase accessible chromatin deep sequencing (ATAC-seq)). Finally, John Rinn (Harvard University, USA) introduced the novel Xrelated lincFIRRE, involved in proximal approximation of nuclear territories. Rinn showed that 6 of the 18 lncRNA knockout strains they had generated exhibit distinct developmental or lethality phenotypes, highlighting the physiological relevance of lncRNAs.
New classes and functions for non-coding RNAs
The first circular RNA (circRNA) was discovered in 1978 from a viroid particle. Since then, many circRNAs have been described in eukaryotes and mammals and several functions have been identified related with this novel class of RNA. Using genome-wide analyses, Nikolaus Rajewsky (Max Delbruck Center for Molecular Medicine, Germany) identified thousands of new cir-cRNAs in human cells, which represent 1% of total RNA. Most of these circRNAs are generated from exonic sequences, are conserved, and are more stable than linear RNAs. The study of 50 of those circRNAs indicated that many are developmentally regulated, and present many miRNA binding sites, suggesting a role as miRNA sponges. Thomas Hansen (Aarhus University, Denmark) delved deeper into circRNA regulation by identifying CiRS-7, which is conserved and highly expressed in the brain and is highly conserved. CiRS-7 inhibits miR-7 function by sequestering the miRNA, and can be repressed selectively by miR-671. Marc Buhler (Friedrich Miescher Institute for Biomedical Research, Switzerland) pointed out that ncRNAs not only act as attractants and guides, but also as evictors of chromatin modifiers. Such as in the case of borderline RNA, a new class of ncRNA that is expressed at insulators to repress the spreading of heterochromatin by evicting Heterochromatin protein 1 (HP1). Finally, Ling-Ling Chen (Shanghai Institutes of Biological Sciences, China) discovered two new classes of polyA(-) excised intron-derived lncRNAs, including linear small nucleolar (sno)-lncRNAs, which are flanked by snoRNA ends, and circular intronic long noncoding RNAs (ciRNAs), which are derived from inefficient debranching after splicing. A sno-lncRNA linked to Prader-Willi syndrome acts as a splicing factor molecular sponge that alters RNA binding protein fox-1 homolog 2 (FOX2)-dependent alternative splicing. The nuclear ciRNA ci-ankrd52 acts as a positive regulator of
